HomeACST • NASDAQ
add
Acasti Pharma Inc
Previous close
$2.94
Day range
$2.80 - $2.92
Year range
$1.72 - $3.59
Market cap
26.60M USD
Avg Volume
13.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.20M | -22.90% |
Net income | -3.17M | 89.12% |
Net profit margin | — | — |
Earnings per share | -0.36 | -18.71% |
EBITDA | -3.20M | 22.78% |
Effective tax rate | 21.92% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.00M | -17.52% |
Total assets | 73.30M | -7.36% |
Total liabilities | 11.56M | 3.48% |
Total equity | 61.74M | — |
Shares outstanding | 9.40M | — |
Price to book | 0.45 | — |
Return on assets | -10.72% | — |
Return on capital | -12.67% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.17M | 89.12% |
Cash from operations | -2.09M | 37.22% |
Cash from investing | 6.55M | 31.17% |
Cash from financing | 0.00 | — |
Net change in cash | 4.46M | 172.95% |
Free cash flow | -1.09M | 28.53% |
About
Founded
2002
Website
Employees
32